We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Primary Angioplasty vs Thrombolysis in Elderly Patients—Reply

Alan K. Berger, MD; Kevin A. Schulman, MD, MBA; Bernard J. Gersh, MB, ChB, DPhil; Nathan R. Every, MD, MPH
JAMA. 2000;283(5):601-602. doi:10.1001/jama.283.5.601.
Text Size: A A A
Published online


In Reply: We attempted to address most of the issues raised by Dr Thiemann in our data analysis. First, as with any observational study, it is impossible to identify and adjust for all differences between patients who receive one therapy vs another. We agree that a randomized clinical trial is the appropriate study design to determine treatment efficacy. However, when data are lacking, as in the case of primary angioplasty in elderly patients, careful observational studies can add important effectiveness data to the debate about treatment choice. Observational studies have the additional benefit of providing real-world data that may support randomized trial findings in more select patients. This is best illustrated by Thiemann's observation of time to treatment in the CCP cohort. Although times in the CCP were substantially longer than the times reported in GUSTO-IIb,1 the longer time to treatment we reported in patients undergoing primary angioplasty is consistent with treatment times reported in the National Registry of Myocardial Infarction2 and is likely to be more representative of community norms than inherent selection bias in the CCP cohort. Furthermore, these longer times to treatment would likely create a bias to reduce the benefit of primary angioplasty.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.